Global X健康科技ETF HEAL 深 滬
已收盤 11-06 16:00:00 美东时间
30.5736
-0.402
-1.30%
華盛通- 最 高30.69
- 今 開30.69
- 成交量 1.72万股
- 最 低 30.2748
- 昨 收 30.9757
- 總市值 3484.76万
- 52周最高 32.15
- 市盈率 靜 --
- 換手率 1.51%
- 52周最低 23.00
- 委 比 -99.50%
- 總股本 113.98万
- 歷史最高 69.0237
- 量 比 0.70
- 振 幅 1.34%
- 歷史最低 23.00
- 每 手 1
- 風險率 2.31%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多HEAL前十大重仓股占比47.0458%，第一大重仓股为Veeva Systems Inc. Class A
数据显示，HEAL前十大重仓股合计占基金资产的47.0458%。 其中，第一大重仓股为Veeva Systems Inc. Class A，持仓占比6.125...
今天 07:08
STERIS Announces Financial Results for Fiscal 2027 Second Quarter
STERIS plc reported a 9% increase in Q2 FY2027 revenue to $1.6 billion, with constant currency organic growth of 8%. Diluted EPS rose to $2.19, and adjusted EPS reached $2.94. The company updated its outlook, reflecting strong performance and $20 million tariff refunds. Healthcare revenue grew 9%, AST by 5%, and Life Sciences by 18%. The outlook now expects 7-8% revenue growth and adjusted EPS of $11.35-$11.55.
11-04 21:30
STERIS Announces Dividend of $0.69 per share
STERIS plc (NYSE: STE) announced a quarterly dividend of $0.69 per share, payable on December 17, 2026, to shareholders of record on November 17, 2026. The company provides healthcare and life science products and services focused on infection prevention. Additional details on U.S. tax treatment are available at www.steris-ir.com.
10-28 20:30
Cellectis Presents Preclinical Data Highlighting Efficient APOC3 Editing and Marked Triglyceride Reduction with .HEAL-101 at ESGCT 2026
Cellectis presented preclinical data for its .HEAL-101, an in vivo base editor targeting APOC3 for severe hypertriglyceridemia. The data showed 70% human APOC3 editing and 76% triglyceride reduction after a single dose in murine models. The therapy demonstrated efficient, specific editing with liver-restricted activity. Cellectis plans to initiate a Phase 1 trial in China, with initial clinical data expected in late 2027.
10-27 07:15
BFB HEALTH（00205.HK）10月26日收盘跌1.23%
证券之星消息，截至2026年10月26日收盘，BFB HEALTH(00205.HK)报收于0.4港元，下跌1.23%，成交量7.0万股，成交额2.8万港元。
10-26 18:48
Quick Heal Technologies Announces Resignation of Company Secretary
Quick Heal Technologies Ltd. ( ($IN:QUICKHEAL) ) has issued an announcement. Qu...
10-20 04:23
BFB HEALTH（00205.HK）10月14日收盘平盘
证券之星消息，截至2026年10月14日收盘，BFB HEALTH(00205.HK)报收于0.42港元，与上一交易日持平，成交量7.0万股，成交额2.94万港元。
10-14 17:58
STERIS to buy Xodus Medical for $2.1B
STERIS (STE) said its wholly owned subsidiary has agreed to acquire Pennsylvania-based surgical products company Xodus Medical for $2.1B at closing, with the deal expected to be financed primarily thr...
10-12 20:08
STERIS Expands Healthcare Consumables Offering with Definitive Agreement to Acquire Xodus Medical, a Specialty Surgical Products Business Focused on Patient and OR Staff Safety
STERIS plc has agreed to acquire Xodus Medical, Inc., a specialty surgical products company, for $2.1 billion, with a net purchase price of $1.8 billion after tax benefits. The deal is expected to close by December 31, 2026, and is projected to enhance STERIS’s product offerings, particularly in surgical consumables, and deliver financial benefits, including top-line growth and margin improvements. Xodus Medical’s 2026 revenue is estimated at $24...
10-12 12:00
TE HEALTHCARE（06877.HK）10月6日收盘跌11.54%
证券之星消息，截至2026年10月6日收盘，TE HEALTHCARE(06877.HK)报收于0.09港元，下跌11.54%，成交量2.5万股，成交额2345.0港元。
10-06 16:59
